Anti-CD47 Antibody ZL-1201 for Patients With Advanced Solid Tumors
Español  |  中國傳統的  |  简体中文
Call us  (855) 528-7322
Main Menu

Anti-CD47 Antibody ZL-1201 for Patients With Advanced Solid Tumors

Sponsor: Zai Lab Co.

Protocol ZL-1201-001. First in Human, Phase I Trial of Anti-CD47 Antibody ZL-1201 in Subjects with Advanced Cancer. A study for patients with previously treated advanced or metastatic solid tumors or lymphoma.